Kalaris Therapeutics Inc (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

5.96

0.11 (1.88%)

At close: May 02, 2025, 3:59 PM

5.83

-2.18%

After-hours: May 02, 2025, 04:05 PM EDT

1.88% (1D)

Bid	5.83
Market Cap	111.47M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
EPS (ttm)	-2.71
PE Ratio (ttm)	-2.2
Forward PE	n/a
Analyst	n/a

Ask	6.1
Volume	32,453
Avg. Volume (20D)	32,945
Open	5.65
Previous Close	5.85
Day's Range	5.55 - 6.32
52-Week Range	5.53 - 24.15
Beta	0.00

About KLRS

Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems....

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Jul 30, 2020

Employees 14

Stock Exchange NASDAQ

Ticker Symbol KLRS

Website https://kalaristx.com/

Full Company Profile